Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Jul;333(3):303-6.
doi: 10.1007/BF00512945.

Variation in behavioral response to baclofen: correlation with benzodiazepine binding sites in mouse forebrain

Variation in behavioral response to baclofen: correlation with benzodiazepine binding sites in mouse forebrain

L Rägo et al. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul.

Abstract

Mice treated with (+/-)baclofen (2 mg/kg i.p.) displayed profound differences to the motor depressant action of this drug. Mice were divided into three groups termed as responders (20%), moderate responders (65%) and nonresponders (15%). No differences were detected in the spontaneous motor activity between the selected groups. When the animal population in the home cages was kept unchanged the different responses to baclofen were reproducible three weeks after selection. A borderline dose of diazepam (1.5 mg/kg) decreased highly significantly motor activity in baclofen responders but failed to do this in nonresponders group. Ex vivo studies with 3H-flunitrazepam (labelling in vivo and binding carried out in vitro) demonstrated that 3H-flunitrazepam binding in mouse forebrain was significantly smaller in baclofen responders than in nonresponders. Further, the apparent number of 3H-flunitrazepam binding sites in vitro was significantly decreased in the forebrain of baclofen responders. It is concluded that some actions of baclofen depend on the functional state of benzodiazepine recognition sites.

PubMed Disclaimer

References

    1. Adv Biochem Psychopharmacol. 1983;38:105-19 - PubMed
    1. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3531-5 - PubMed
    1. Life Sci. 1984 Jun 25;34(26):2647-53 - PubMed
    1. Mol Pharmacol. 1984 May;25(3):352-9 - PubMed
    1. Nature. 1981 Mar 12;290(5802):149-52 - PubMed